| Andrew Callos |
CYTK |
Common Stock |
Sale |
-2.41% |
$119,795 |
$62.07 |
-1,930 |
78,185 |
18 Mar 2026 |
Direct |
| Sung Lee |
CYTK |
Common Stock |
Sale |
-5.36% |
$306,710 |
$62.15 |
-4,935 |
87,127 |
17 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-10.7% |
$530,885 |
$62.15 |
-8,542 |
71,573 |
17 Mar 2026 |
Direct |
| Fady Ibraham Malik |
CYTK |
Common Stock |
Sale |
-7.25% |
$747,851 |
$62.15 |
-12,033 |
153,902 |
17 Mar 2026 |
Direct |
| Robert I. Blum |
CYTK |
Common Stock |
Sale |
-7.84% |
$2,274,752 |
$62.15 |
-36,601 |
430,330 |
17 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-3.57% |
$104,300 |
$61.03 |
-1,709 |
46,149 |
16 Mar 2026 |
Direct |
| Robert I. Blum |
CYTK |
Common Stock |
Award |
19.2% |
|
|
75,258 |
466,931 |
15 Mar 2026 |
Direct |
| Robert I. Blum |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Award |
|
|
|
111,864 |
111,864 |
15 Mar 2026 |
Direct |
| Robert I. Blum |
CYTK |
Incentive Stock Option (Right to Buy) |
Award |
|
|
|
1,665 |
1,665 |
15 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Award |
71% |
|
|
33,966 |
81,824 |
15 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Award |
|
|
|
29,480 |
29,480 |
15 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Incentive Stock Option (Right to Buy) |
Award |
|
|
|
1,665 |
1,665 |
15 Mar 2026 |
Direct |
| Jeffrey Hessekiel |
CYTK |
Common Stock |
Award |
23.6% |
|
|
20,646 |
107,943 |
15 Mar 2026 |
Direct |
| Jeffrey Hessekiel |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Award |
|
|
|
22,820 |
22,820 |
15 Mar 2026 |
Direct |
| Jeffrey Hessekiel |
CYTK |
Incentive Stock Option (Right to Buy) |
Award |
|
|
|
8,325 |
8,325 |
15 Mar 2026 |
Direct |
| Sung Lee |
CYTK |
Common Stock |
Award |
28.9% |
|
|
20,646 |
92,062 |
15 Mar 2026 |
Direct |
| Sung Lee |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Award |
|
|
|
29,480 |
29,480 |
15 Mar 2026 |
Direct |
| Sung Lee |
CYTK |
Incentive Stock Option (Right to Buy) |
Award |
|
|
|
1,665 |
1,665 |
15 Mar 2026 |
Direct |
| Fady Ibraham Malik |
CYTK |
Common Stock |
Award |
19.7% |
|
|
27,306 |
165,935 |
15 Mar 2026 |
Direct |
| Fady Ibraham Malik |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Award |
|
|
|
39,527 |
39,527 |
15 Mar 2026 |
Direct |
| Fady Ibraham Malik |
CYTK |
Incentive Stock Option (Right to Buy) |
Award |
|
|
|
1,665 |
1,665 |
15 Mar 2026 |
Direct |
| Robert I. Blum |
CYTK |
Common Stock |
Sale |
-1.98% |
$481,570 |
$60.72 |
-7,931 |
391,673 |
09 Mar 2026 |
Direct |
| Fady Ibraham Malik |
CYTK |
Common Stock |
Sale |
-2.05% |
$176,513 |
$60.72 |
-2,907 |
138,629 |
09 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-5.12% |
$156,779 |
$60.72 |
-2,582 |
47,858 |
09 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-34% |
$1,608,730 |
$61.87 |
-26,000 |
50,440 |
05 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Options Exercise |
51.6% |
|
|
26,000 |
76,440 |
05 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Options Exercise |
-51.6% |
|
|
-26,000 |
24,403 |
05 Mar 2026 |
Direct |
| B. Lynne Parshall |
CYTK |
Common Stock |
Sale |
-21.8% |
$306,050 |
$61.21 |
-5,000 |
17,933 |
02 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-1.73% |
$54,595 |
$61.62 |
-886 |
50,440 |
02 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Options Exercise |
1.76% |
|
|
886 |
51,326 |
02 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Incentive Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-886 |
0 |
02 Mar 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-22.9% |
$928,950 |
$61.93 |
-15,000 |
50,440 |
05 Feb 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Options Exercise |
29.7% |
|
|
15,000 |
65,440 |
05 Feb 2026 |
Direct |
| Andrew Callos |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Options Exercise |
-15.2% |
|
|
-15,000 |
84,000 |
05 Feb 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-1.73% |
$55,021 |
$62.10 |
-886 |
50,440 |
02 Feb 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Options Exercise |
1.76% |
|
|
886 |
51,326 |
02 Feb 2026 |
Direct |
| Andrew Callos |
CYTK |
Incentive Stock Option (Right to Buy) |
Options Exercise |
-50% |
|
|
-886 |
886 |
02 Feb 2026 |
Direct |
| James M. Daly |
CYTK |
Common Stock |
Award |
|
|
|
197 |
197 |
15 Jan 2026 |
Direct |
| Nancy Wysenski |
CYTK |
Common Stock |
Award |
0.32% |
|
|
98 |
30,971 |
15 Jan 2026 |
Direct |
| Wendell Wierenga |
CYTK |
Common Stock |
Award |
0.3% |
|
|
98 |
32,542 |
15 Jan 2026 |
Direct |
| Edward M. Kaye MD |
CYTK |
Common Stock |
Award |
1.97% |
|
|
197 |
10,174 |
15 Jan 2026 |
Direct |
| Henderson John T. |
CYTK |
Common Stock |
Award |
0.45% |
|
|
334 |
74,912 |
15 Jan 2026 |
Direct |
| Robert Arthur Harrington |
CYTK |
Common Stock |
Award |
1.06% |
|
|
197 |
18,739 |
15 Jan 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-22.9% |
$904,200 |
$60.28 |
-15,000 |
50,440 |
05 Jan 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Options Exercise |
29.7% |
|
|
15,000 |
65,440 |
05 Jan 2026 |
Direct |
| Andrew Callos |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Options Exercise |
-13.2% |
|
|
-15,000 |
99,000 |
05 Jan 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Options Exercise |
1.75% |
|
|
885 |
51,325 |
02 Jan 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-3.44% |
$112,585 |
$62.62 |
-1,798 |
50,440 |
02 Jan 2026 |
Direct |
| Andrew Callos |
CYTK |
Incentive Stock Option (Right to Buy) |
Options Exercise |
-33.3% |
|
|
-885 |
1,772 |
02 Jan 2026 |
Direct |
| Andrew Callos |
CYTK |
Common Stock |
Sale |
-3.4% |
$112,954 |
$62.44 |
-1,809 |
51,353 |
29 Dec 2025 |
Direct |